$Liquidia (LQDA.US)$ PDUFA;FDA update📢 ⇒ NDA review remain...

$Liquidia(LQDA.US)$ PDUFA;FDA update📢

⇒ NDA review remains ongoing
⇒ Confirms the process for adding the PH-ILD
indication as an amendment
⇒ Couldn't issue an action letter in time

📍• YUTREPIA
⇒ PDUFA goal date: 1/24/24
⇒ NDA
⇒ PH-ILD